For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Sage Therapeutics Inc (NASDAQ: SAGE) was $6.48 for the day, down -0.61% from the previous closing price of $6.52. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 0.67 million shares were traded.
Ratios:
Our analysis of SAGE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.13 and its Current Ratio is at 9.13. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On November 21, 2024, RBC Capital Mkts Upgraded its rating to Sector Perform which previously was Underperform but kept the price unchanged to $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 10 ’24 when JONAS JEFFREY M bought 7,500 shares for $5.53 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 8.56 while its Price-to-Book (P/B) ratio in mrq is 0.99.
Stock Price History:
Over the past 52 weeks, SAGE has reached a high of $13.47, while it has fallen to a 52-week low of $4.62. The 50-Day Moving Average of the stock is -11.51%, while the 200-Day Moving Average is calculated to be -7.16%.
Shares Statistics:
A total of 62.54M shares are outstanding, with a floating share count of 55.09M. Insiders hold about 12.03% of the company’s shares, while institutions hold 85.36% stake in the company.
